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Abstract
Introduction Metastasis involves the emigration of tumor cells
through the vascular endothelium, a process also known as
diapedesis. The molecular mechanisms regulating tumor cell
diapedesis are poorly understood, but may involve heterocellular
gap junctional intercellular communication (GJIC) between
tumor cells and endothelial cells.
Method To test this hypothesis we expressed connexin 43
(Cx43) in GJIC-deficient mammary epithelial tumor cells
(HBL100) and examined their ability to form gap junctions,
establish heterocellular GJIC and migrate through monolayers of
human microvascular endothelial cells (HMVEC) grown on
matrigel-coated coverslips.
Results HBL100 cells expressing Cx43 formed functional
heterocellular gap junctions with HMVEC monolayers within 30
minutes. In addition, immunocytochemistry revealed Cx43
localized to contact sites between Cx43 expressing tumor cells
and endothelial cells. Quantitative analysis of diapedesis
revealed a two-fold increase in diapedesis of Cx43 expressing
cells compared to empty vector control cells. The expression of
a functionally inactive Cx43 chimeric protein in HBL100 cells
failed to increase migration efficiency, suggesting that the
observed up-regulation of diapedesis in Cx43 expressing cells
required heterocellular GJIC. This finding is further supported by
the observation that blocking homocellular and heterocellular
GJIC with carbenoxolone in co-cultures also reduced
diapedesis of Cx43 expressing HBL100 tumor cells.
Conclusion Collectively, our results suggest that heterocellular
GJIC between breast tumor cells and endothelial cells may be
an important regulatory step during metastasis.
Introduction
Tumor metastasis is a multi-step process that involves the dis-
sociation of tumor cells from the primary tumor followed by
their entry into the circulation, extravasation from the vascular
system and proliferation into tumor masses at secondary tis-
sue sites. Both cell-cell and cell-matrix interactions are impor-
tant regulators at different stages of this metastatic cascade
[1-4]. For instance, loss of E-cadherin in bladder, prostate,
breast and colorectal cancers, or integrins such as α 2β 1 and
α 5β 1 in breast cancer and α 6β 1 in melanoma cells correlates
with increased malignancy of tumor cells, indicating that the
integrity of the primary tumor depends on signals from adja-
cent cells and from appropriate extracellular matrix ligands
[1,2,5-8].
Extravasation of malignant cells often involves transendothelial
migration (diapedesis) into tissues prior to forming secondary
tumors. In contrast to diapedesis of leukocytes during inflam-
matory responses, little is known about the molecular mecha-
nisms that regulate tumor cell diapedesis. The integrity of the
endothelium depends mainly on the organization of interen-
dothelial junctions, and tumor cells must traverse these junc-
tions to extravasate across the endothelial barrier. Our
previous studies demonstrated that diapedesis of melanoma
cells is in part regulated by adhesion receptors present on
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both the vascular endothelium and the tumor cell [9]. A local-
ized disruption in the endothelium of vascular endothelial (VE)-
cadherin, α -catenin and platelet endothelial cell adhesion mol-
ecule-1 (PECAM-1) occurs at the site of tumor cell penetra-
tion, which is restored once the tumor cell completes
diapedesis [9]. We further demonstrated that endothelial N-
cadherin is necessary for the completion of melanoma cell dia-
pedesis, suggesting that endothelial cells actively participate
in the process of tumor cell diapedesis [9]. Integrins appear to
play an important role during extravasation of tumor cells by
binding to components in the extracellular matrix and on
endothelial cells. The integrin α vβ 3 regulates diapedesis of
melanoma cells by binding to the immunoglobulin like adhe-
sion receptor L1 on endothelial cells [10]. In prostate tumor
cells, β 3 integrins regulate diapedesis by binding to matrix
components underneath the endothelium [11] and, in breast
tumor cells, integrins β 1, α 5 and α vβ 3 are involved in adhesion
and migration through the extracellular matrix components vit-
ronectin and fibronectin [12]. In addition, it has been reported
that integrins mediate invasion and metastasis in murine
melanoma cells and gliomas [13,14].
These previous studies suggest that signaling via cell-cell and
cell-matrix adhesion receptors facilitates tumor cell diapede-
sis. Another possible mechanism by which tumor cells may
communicate with endothelial cells to cross the endothelial
barrier involves gap junctions [15-17]. Gap junctions are inter-
cellular channels that mediate the direct intercellular exchange
of secondary messengers, small metabolites or inorganic ions
[18]. These channels are located at the plasma membrane and
are composed of two hemichannels called connexons, each of
which is assembled from six oligomerized protein subunits
called connexins (Cx) [18,19]. To date the connexin family
includes 20 members named according to their predicted
molecular weights [20]. Connexin expression varies between
cell types, and individual cells often express more than one
connexin family member [18,21]. Although endothelial cells
are heterogeneous according to the size of the vessel or the
vascular bed of origin, they all express three different types of
connexin, Cx43, Cx37 and Cx40 [22-26]. In normal human
mammary glandular epithelium, Cx43 is found most often
between mammary myoepithelial cells and in luminal cells,
while adjacent luminal cells predominantly assemble Cx26
gap junctions [27,28]. Studies have demonstrated a decrease
in gap junctional intercellular communication (GJIC) and con-
nexin expression or aberrant connexin trafficking and assembly
in primary mammary tumors [29-31]. Little is known, however,
about connexin expression and GJIC in tumor cells en route to
secondary metastatic sites outside the site of the primary dis-
eased tissue. Previous studies have observed apparent gap
junction formation between mammary tumor and vascular
endothelial cells but the consequences of this interaction were
not established [15,16]. In another study, Cx26 expressing
BL6 mouse melanoma cells were found to form tumor/
endothelial cell heterocellular gap junctions and these con-
nexin expressing tumor cells had increased metastatic proper-
ties in vivo [17]. These findings are puzzling as Cx26 is not
generally capable of forming heterotypic gap junctions with
any of the endothelial expressed connexins, which include
Cx40, Cx37 and Cx43 [32].
Previous studies investigating GJIC between tumor cells and
endothelial cells focused primarily on tumor cell adhesion to
the endothelium during the initial stages of diapedesis [15-
17]. To address the hypothesis that GJIC may affect diapede-
sis, we used a non-metastatic cell line (HBL100) that is GJIC-
deficient and does not express any known connexins in order
to better evaluate a possible contribution of GIJC to diapede-
sis. Because endothelial cells abundantly express Cx43, we
engineered HBL100 cells to express either wild-type Cx43 or
a non-functional chimeric mutant of Cx43 to determine if the
potential of HBL100 cells to cross the endothelium would
change under both or either of these conditions. In this report
we show that Cx43 expression up-regulates tumor cell diaped-
esis via a GJIC-dependent mechanism.
Materials and methods
Cell lines and culture conditions
Human microvascular endothelial cells (HMVECs) derived
from the lung were purchased from Cambrex Biosciences Inc.
(Walkersville, MD, USA) and cultured according to supplier's
instructions in endothelial growth medium (EGM; Cambrex
Biosciences Inc.), supplemented with 100 units/ml penicillin
G sodium, and 100 µg/ml streptomycin sulphate (Invitrogen,
Burlington, ON, Canada). Wild-type transformed mammary
epithelial cells (HBL100) and HBL100 cells expressing Cx43
or Cx43 with green fluorescent protein (GFP) tagged to the
amino terminal (GFP-Cx43) [33] were routinely cultured in D-
MEM supplemented with 100 units/ml penicillin G sodium,
100 µg/ml streptomycin, 2 mM L-glutamine (Invitrogen) and
10% FBS (Sigma-Aldrich, Oakville, ON, Canada). All cells
were maintained in a humidified chamber at 37°C containing
5% CO2.
Constructs, infection and transfection
HBL100 cells expressing Cx43 (HBL100Cx43) or empty vec-
tor (HBL100v) were engineered by retroviral infection as
described by Qin et al. [34]. Briefly the cDNA of Cx43 inserted
into the AP-2 retroviral vector was transfected into the
293GPG packaging cell line and 48 h later retroviral superna-
tant was collected and filtered through a 0.45 µm filter and
used to infect HBL100 cells. Twenty-four hours after infection,
medium was replaced with D-MEM and cells were subcultured
as normal. More than 90% of tumor cells expressed Cx43 after
three rounds of viral infection as determined by immunofluo-
rescence [34].
HBL100 cells expressing non-functional GFP-Cx43
(HBL100GFP-Cx43) [33] were generated by transfecting 2.5
× 105  HBL100 cells with 2 µg of GFP-Cx43 usingAvailable online http://breast-cancer-research.com/content/7/4/R522
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Metafectene (Biontex Laboratories GmbH, Munich, Germany).
After 24 h, approximately 40% of cells expressed GFP-Cx43
and these cells were used for diapedesis assays.
Diapedesis assay
The diapedesis assay was carried out as previously described
[9]. Briefly, 7.5 × 105 HMVECs were seeded onto 12 mm
glass coverslips coated with matrigel (Becton-Dickenson,
Bedford, MA, USA). HMVEC cells were allowed to settle for
2–3 h and form monolayers in a 37°C humidified chamber
containing 5% CO2. Coverslips were then transferred to a 24-
well plate and cultured for 48 h in EGM. The number of cells
seeded produces an endothelial monolayer without requiring
cell proliferation. Monolayers have intact adherens junctions
as previously evaluated by VE-cadherin staining [9,35].
HBL100 tumor cells were labeled with 10 µg/ml 1,1'-diocta-
decyl-3, 3,3', 3'-tetramethylindocarbocyanine percholate (DiI;
Molecular Probes, Eugene, OR, USA), and harvested non-
enzymatically using 2 mM EDTA (EMD Chemicals Inc., Gibbs-
town, NJ, USA). Approximately 7.5 × 104 cells were added to
endothelial monolayers at a ratio of around 1:10 (tumor
cell:endothelial cell). Cells were then co-cultured for different
times (1, 5, or 7 h) before live observation or fixation and immu-
nostaining. Diapedesis was quantified blinded to the investiga-
tors using a Leica IRE2-DM epifluorescence microscope
(Leica Microsystems Inc., Toronto, ON, Canada) as previously
described [11]. Briefly, co-cultures were fixed and stained for
F-actin. Diapedesis was quantified by counting the number of
tumor cells in contact with the endothelium classified into
three stages according to their position relative to the
endothelium: round on top (tumor cells with a spherical shape
located on the apical surface of the endothelium); migrating
(tumor cells have penetrated through the endothelial monol-
ayer at endothelial cell junctions where part of the cell body is
located above the endothelium and part of it has spread on the
matrigel, beneath the endothelial cell f-actin stress fibers); and
underneath (all of the tumor cell body is below the plane of the
endothelial cell stress fibers). Migrating and underneath cells
were scored together as transmigrating. For each coverslip,
approximately 100 cells adherent to the endothelium were
scored and counted and all experiments were repeated three
times with triplicate coverslips.
Pre-loading dye coupling assay
GJIC was evaluated using the preloading dye coupling assay
as described previously [36] with the following modifications.
Tumor cells were labeled for 15 minutes at 37°C with 2 ml of
Opti-MEM (Invitrogen) containing 10 µg/ml calcein-AM and
10 µg/ml DiI. Calcein-AM is a fluorescent substrate that is
cleaved in viable cells into a membrane impermeable form able
to pass through functional gap junctions but not through other
plasma membrane channels. Labeled tumor cells were
washed twice with Hank's balanced salt solution (HBSS), har-
vested non-enzymatically using 2 mM EDTA, and added to
HMVEC monolayers on matrigel. Dye transfer from tumor cells
to endothelial cells was observed live by epifluorescence
microscopy after 30 minutes of co-culture and the number of
adherent tumor cells that transferred dye to adjacent endothe-
lial cells was scored and expressed as percent of total number
of tumor cells counted. For each coverslip, approximately 70
cells adherent to the endothelium were scored. Unless speci-
fied, all experiments were repeated three times with triplicate
coverslips.
GJIC as assessed by fluorescence recovery after 
photobleaching
To determine whether carbenoxolone (CBX) blocks gap junc-
tional coupling, HMVEC monolayers were pretreated for 7 h
with 150 µM CBX or the inactive analog glycyrrhizic acid
(GZA). HMVEC were then loaded for 15 minutes with 10 µg/
ml calcein-AM (Molecular Probes) in an Opti-MEM solution
containing CBX or GZA. Cells were rinsed twice with Opti-
MEM containing CBX or GZA and immersed in fresh media
containing CBX or GZA. Because the fluorescent dye can only
pass through gap junctions, recovery of fluorescence in the
bleached cell will only occur if dye passes through gap junc-
tions with adjoining unbleached cells. For each experimental
condition, three individual cells were bleached for approxi-
mately 30 s using the Zeiss laser scanning confocal micro-
scope (LSM) 410 and an argon laser at full power. To observe
recovery of fluorescence, images were obtained every five
minutes following photobleaching using the argon laser at
33% power until maximum recovery was reached (15 min-
utes). In control experiments, monolayers were left untreated
or were treated with the inactive analog of CBX, GZA. Mean
fluorescence intensity of bleached/unbleached cells in the
same area was measured over time using scion imaging soft-
ware and expressed as mean relative recovery (arbitrary units).
Data represent three independent experiments.
Immunofluorescence staining and laser scanning 
confocal microscopy
Cells were fixed at room temperature for 20 minutes with 2%
or 4% (w/v) paraformaldehyde (EMD Chemicals Inc.) and
washed in cation free phosphate buffered saline (PBS). Cells
were permeabilized for five minutes at 4°C using a buffer con-
taining 15 mM Tris-HCL, 120 mM sodium chloride (NaCl), 25
mM potassium chloride (KCl), 2 mM EDTA, 2 mM EGTA, 0.5%
(v/v) Triton X-100, pH 7.5. To label F-actin, co-cultures were
incubated for 30 minutes at room temperature with Alexa
Fluor® 488 or Texas Red conjugated-phalloidin (Molecular
Probes) diluted 1:50 in PBS with 1% (w/v) bovine serum albu-
min (BSA) followed by three washes in PBS. To examine the
localization of F-actin and Cx43, cells were labeled with Texas
red conjugated-phalloidin (1:50 dilution) and with monoclonal
anti-Cx43 (clone P4G9 from the Fred Hutchinson Cancer
Research Center Antibody Development Group, Seattle, WA,
USA) diluted 1:10 in 1% (w/v) BSA/PBS. Cells were incu-
bated with Alexa Fluor® 488-conjugated goat-anti-mouse sec-
ondary antibody (Molecular Probes). Nuclei were stainedBreast Cancer Research    Vol 7 No 4    Pollmann et al.
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using 10 µg/ml Hoechst 33342 (Sigma-Aldrich) diluted in
PBS. Coverslips were mounted on glass slides using vectash-
ield mounting media (Vector Laboratories, Burlington, ON,
Canada) and sealed with nail enamel. The inclusion of spacers
made from plastic coverslips cut into strips prevented contact
of co-cultures with the slides as described by Voura et al. [37].
Co-cultures were imaged using a Zeiss LSM 410 laser scan-
ning confocal microscope system (Carl Zeiss Canada Ltd,
Toronto, ON, Canada). Serial 0.7 µm optical sections of
selected areas were recorded and evaluated with the LSM
410 software (Carl Zeiss Canada Ltd). Representative serial
optical sections are presented in an apical to basal direction.
Adhesion assay
Adhesion to the endothelium was evaluated as previously
described for leukocyte adhesion to the endothelium [38] with
the following modifications. HMVEC monolayers were estab-
lished in 1:20 matrigel coated wells (2.1 × 104 cells per well)
and cultured for 48 h. HBL100, HBL100v, or HBL100Cx43
cells (2.1 × 103), pre-labeled with DiI, were added to HMVEC
monolayers and co-cultured for 1 h. Co-cultures were fixed
with 2% (w/v) paraformaldehyde and washed twice with PBS
to remove non-adherent cells. The PBS was replaced with
water and fluorescence intensity of DiI was measured for each
well at 549 nm excitation and 565 nm emission wavelengths
using a SAFIRE fluorescent microplate reader (Tecan US Inc.,
Durham, NC, USA). The number of adherent tumor cells was
calculated and normalized based on a standard curve gener-
ated with known numbers of DiI-labeled tumor cells present in
duplicate wells in the same microplate. Experiments were
repeated three times with eight sample replicates per cell type.
Protein extraction and western blot analysis
HBL100, HBL100v, HBL100Cx43, HBL100GFP-Cx43, and
HMVEC cells grown in culture dishes were lysed using the fol-
lowing buffer for protein collection: 10 mM Tris (pH 7.4), 150
mM NaCl, 1 mM EDTA, 0.1% (w/v) SDS, and 0.5% (v/v) Triton
X-100. Protein concentration was determined with bicin-
choninic acid (BCA) protein assay reagent (Pierce Chemical
Co., Rockford, IL, USA). Protein (50 µg) for each cell type was
separated in 12% SDS-polyacrylamide gels and transferred to
nitrocellulose membranes. Nitrocellulose membranes were
blocked with 5% non-fat dry milk in tris buffered saline (TBS)
containing 5% Tween 20. Membranes were then probed for
Cx43 protein, using a monoclonal anti-Cx43 antibody against
amino-terminal amino acid residues 1–20 (clone P1E11 from
the Fred Hutchinson Cancer Research Center Antibody
Development Group, Seattle, WA, USA) at a dilution of 1:500.
Immunoblots were probed with appropriate secondary anti-
bodies conjugated to horse radish peroxidase (Pierce Chemi-
cal Co.) at a dilution of 1:10,000. The protein was visualized
using Supersignal West Pico Chemiluminescent substrate
(Pierce Chemical Co.) by exposing the immunoblot to Amer-
sham Hyperfilm (Amersham Biosciences, Piscataway, NJ,
USA) for 30 s.
Statistical analysis
Comparisons between cell types and different time points or
treatments were evaluated using a two-way analysis of vari-
ance followed by Bonferroni post-hoc test. A p-value of < 0.05
was considered to be significant. Comparisons between cell
types at a single time point were evaluated using one-way
analysis of variance followed by Tukey's multiple comparison
post-hoc test. Data are presented as means +/- SEM.
Results
Morphological evaluation of tumor cell diapedesis
Previous work suggested that GJIC between tumor cells and
endothelial cells may affect diapedesis during metastasis [15-
17]. To analyze and evaluate the efficiency of breast tumor cell
diapedesis we used an in vitro assay in which tumor cells were
allowed to migrate through a monolayer of endothelial cells
grown on matrigel as we have previously described [9,39-41].
This assay mimics aspects of the vessel wall and has been
used by us [35,42] and others [39-41] to analyze leukocyte
diapedesis. Diapedesis was assessed by evaluating the spa-
tial location of tumor cells as they migrated through an
endothelial monolayer. Tumor cells pre-labeled with DiI were
seeded for 1, 5 or 7 h onto endothelial monolayers before fix-
ation and stained for F-actin. Tumor cells were scored accord-
ing to their morphology and location with respect to the
endothelium. We defined three distinct stages of migration
observable by confocal microscopy (Fig. 1): top; migrating;
and underneath. Tumor cells located on top of the endothelium
prior to diapedesis tended to have a round or oval shape with
small filopodia extending from the periphery of the cell (Fig. 1b,
arrows). This shape was maintained from the apical (Fig. 1b)
to the basal surface (Fig. 1d) of the tumor cell, differing from
melanoma cells, which tend to have a fibroblastic shape and
spread on the apical endothelial surface [37]. At sites of tumor
cell-endothelial cell interactions, prominent microfilament bun-
dles within the underlying endothelial cell were seen, indicat-
ing no disruption of the endothelium (Fig. 1d). Tumor cells in
the process of diapedesis (migrating) had a unique morphol-
ogy with distinct shapes at various focal levels (Fig. 1f–h) not
previously seen in melanoma cells [37] but very similar to
transmigrating monocytes and prostate tumor cells [11,35].
The apical aspect of migrating tumor cells located above the
endothelium was round in shape and lacking filopodial exten-
sions, but contained smooth cortical actin staining (Fig. 1f). At
the level of the endothelium, tumor cells maintained close con-
tact with the endothelial cells, which formed a circular opening
surrounded by thick bundles of F-actin (Fig. 1g, arrow). The
basal aspect of the tumor cells was located underneath the
endothelium and spread along the matrigel by extending proc-
esses in various directions (Fig. 1h, arrows). Tumor cells
located completely underneath the endothelium (Fig. 1j–l) had
endothelial microfilament bundles extended over the top of theAvailable online http://breast-cancer-research.com/content/7/4/R522
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tumor cell as previously seen in melanoma cells [37]. No open-
ing above the tumor cell remained, indicating complete closure
of the transmigration passage (Fig. 1j). Tumor cells under-
neath the endothelium spreading on the surface of the matrigel
had an irregular shape and stress fibers (Fig. 1l, arrows). The
morphological features of HBL100v or HBL100Cx43 cells
(not shown) during diapedesis were not noticeably different
from those of HBL100 wild-type cells. We used the morpho-
logical criteria shown in Fig. 1 to quantify various stages and
assess the efficiency of diapedesis.
Expression and distribution of exogenous Cx43 in 
HBL100 cells and HMVEC monolayers
To explore if Cx43 expression in HBL100 cells affects any
aspects of diapedesis, cells were engineered to express func-
tional Cx43, non-functional GFP-Cx43 or the empty retroviral
Figure 1
Tumor cell diapedesis through human microvascular endothelial cell (HMVEC) monolayers Tumor cell diapedesis through human microvascular endothelial cell (HMVEC) monolayers. HBL100 cells were pre-labeled with dioctadecyl-3, 3,3', 
3'-tetramethylindocarbocyanine percholate (DiI; red), co-cultured with HMVEC monolayers for various time periods, fixed with paraformaldehyde and 
labeled for F-actin (green). Optical sections obtained by laser scanning confocal microscopy at the focal levels indicated in (a,e,i) identified three 
major stages of diapedesis: round on top of (a-d), migrating through (e-h), or located underneath (i-l) the endothelium. (b) Cells round on top had 
filopodial extensions present on the apical surface of a cell (arrows). (g) Thick bundles of F-actin were present at the interface between endothelial 
cells and the migrating tumor cell (arrow). (h) Migrating tumor cells with portions spread underneath the endothelium (arrows) and (i) those that 
completed diapedesis often contained prominent stress fibers underneath the endothelium (arrows). No major morphological differences between 
wild-type and connexin43 (Cx43) expressing HBL100 cells were observed. Bar = 10 µm.Breast Cancer Research    Vol 7 No 4    Pollmann et al.
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vector as a control. Cx43 was absent in both wild-type and
empty vector HBL100v control cell lines used (Fig. 2a,c,d) but
expressed in HMVEC (Fig. 2a,b) and cells engineered to
express Cx43 (Fig. 2a,e) or GFP-Cx43 (Fig. 2a,f). Importantly,
both Cx43 and GFP-Cx43 were routinely observed to localize
to the cell surface, consistent with the formation of gap junc-
tion plaques (Fig. 2b,e,f). Intracellular populations of Cx43
likely reflecting different stages of assembly or degradation in
HMVEC, HBL100Cx43 and HBLGFP-Cx43 were also seen.
These results suggest that exogenous or endogenously
expressed Cx43 assembles into gap junctional plaques at
sites of homocellular endothelial or tumor cell-cell contacts.
HBL100vCx43 cells form functional gap junctional 
channels with HMVEC monolayers
To determine whether HBL100 cells engineered to exoge-
nously express Cx43 formed gap junctions and established
GJIC with HMVEC cells, we co-cultured HBL100Cx43 with
HMVEC monolayers, localized Cx43 in these cultures (Fig.
3a–c), and assayed for dye transfer between tumor and
endothelial cells (Fig. 3d–j). Confocal microscopy revealed
Cx43 at tumor cell-endothelial cell interfaces (Fig. 3b, arrows)
where tumor cells were wedged between endothelial cells and
where cortical F-actin was found (Fig. 3b,c). These results
indicate that during diapedesis HBL100Cx43 cells form hete-
rocellular gap junctions with adjacent endothelial cells.
Preloading dye transfer studies to assess whether Cx43 is
being assembled into functional gap junctions at tumor/
endothelial cell interfaces revealed that dye spread extensively
from Cx43 expressing HBL100 cells to endothelial cells (Fig.
3i), whereas dye failed to spread from control HBL100v cells
to endothelial cells (Fig. 3f). These results suggest that exog-
enous Cx43 in HBL100Cx43 can form functional gap junc-
tions with HMVEC early on during diapedesis. Live
quantification of coupling performed after 30 minutes of co-
culture revealed that ten times more Cx43 expressing
HBL100 cells coupled to the endothelium than those lacking
Cx43 (Fig. 3j). The low occurrence of dye transfer between
HBL100v control cells and HMVEC is likely due to nonspecific
dye uptake from damaged tumor cells rather than functional
gap junctional coupling due to connexin expression.
Cx43 enhances HBL100 diapedesis
To compare the efficiency of diapedesis of Cx43 deficient
tumor cells with those that exogenously express Cx43, we co-
cultured HBL100, HBL100v or HBL100Cx43 cells with
HMVEC for 1, 5 and 7 h. At all time points HBL100Cx43 cells
showed an up to two-fold increase in diapedesis efficiency
compared to cells lacking Cx43 (Fig. 4a). This increase in
migration appeared to plateau at 5 h. Conversely, at all time
points no statistical difference in migration efficiency was
observed between wild-type (HBL100) and control
(HBL100v) cells (Fig. 4a). The relative proportion of cells at
different stages of migration was evaluated after 7 h of co-cul-
ture (Fig. 4b). About 50% of wild-type and vector control cells
encountered were located on top of the endothelium, 40%
were migrating across the endothelium, and about 10% were
completely located underneath. In contrast, only 20% of
HBL100Cx43 cells were located on top of the endothelium,
while over 60% migrated across. No significant difference in
the relative proportion of cells underneath the endothelium
was observed between HBL100 cells with or without Cx43
Figure 2
Exogenous connexin43 (Cx43) in HBL100 cells forms gap junctional  plaques Exogenous connexin43 (Cx43) in HBL100 cells forms gap junctional 
plaques. To explore if Cx43 expression and/or gap junctional intercellu-
lar communication (GJIC) affects diapedesis of breast tumor cells we 
used GJIC-deficient HBL100 cells to engineer cells expressing func-
tional Cx43 (HBL100Cx43) and non-functional Cx43 (HBL100GFP-
Cx43). HBL100v, containing the empty expression vector, served as a 
control. (a) Cx43 expression of these cells was compared by western 
blot analysis to that of human microvascular endothelial cell (HMVEC) 
grown on matrigel used as a control for endogenous Cx43 expression. 
Whereas Cx43 was undetectable in HBL100 and HBL100v cells, 
HMVEC grown on matrigel, HBL100Cx43, and HBL100GFP-Cx43 
cells expressed Cx43. Immunocytochemistry localized Cx43 at cell-cell 
borders in (b) HMVEC monolayers (arrows), (e) between 
HBL100Cx43 cells (arrow) or (f) HBL100GFP-Cx43 cells (arrows), 
whereas (c) HBL100 and (d) HBL100v cells lacked Cx43 staining. Bar 
= 10 µm.Available online http://breast-cancer-research.com/content/7/4/R522
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Figure 3
Connexin43 (Cx43) localizes to tumor/endothelial cell interfaces and assembles into functional gap junction channels Connexin43 (Cx43) localizes to tumor/endothelial cell interfaces and assembles into functional gap junction channels. To examine Cx43 distribution 
during tumor cell diapedesis, cells expressing functional Cx43 (HBL100Cx43) were co-cultured with human microvascular endothelial cell (HMVEC) 
monolayers, fixed and labeled for (b) Cx43 (green) and (c) F-actin (red). The optical section obtained by confocal microscopy revealed (b) Cx43 
(arrows) enriched at tumor cell (T)/endothelial cell (e) contact site, where it partially co-localizes with cortical F-actin. (a) Schematic diagram indicat-
ing the level of the optical section where the tumor cell is wedged between the endothelial cells and (b) the location of the Cx43-containing plaques 
(arrows). To evaluate if expression of exogenous Cx43 in HBL100 cells resulted in formation of functional gap junctions with HMVEC, (f) HBL100v 
or (i) HBL100Cx43 cells (arrows) were preloaded with (e,h) dioctadecyl-3, 3,3', 3'-tetramethylindocarbocyanine percholate (DiI; red) and (f,i) cal-
cein-AM (green) and co-cultured with HMVEC monolayers for 30 minutes. Live observation of the co-cultures revealed that in contrast to (d-f) 
HBL100v cells, (g-i) HBL100Cx43 cells allowed the calcein dye to spread to adjacent HMVEC cells. (j) Gap junctional intercellular communication 
(GJIC) between tumor cells and endothelial cells was quantified live after 30 minutes of co-culture, revealing a 10-fold increase in the number of con-
nexin expressing tumor cells coupled to the endothelium compared to tumor cells lacking Cx43 (*p < 0.05). Bar = (c) 10 µm and (f,i) 50 µm.Breast Cancer Research    Vol 7 No 4    Pollmann et al.
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expression (Fig. 4b). These results suggested that Cx43
facilitated tumor cell diapedesis but it was unclear if this was
due to increased adhesiveness or whether GJIC was required.
To determine whether the increase in diapedesis efficiency
was due to increased adhesive properties of Cx43 expressing
tumor cells, we co-cultured HBL100, HBL100v and
HBL100Cx43 cells on endothelial cells and compared the
number of DiI labeled tumor cells adherent to HMVEC monol-
ayers using fluorescence intensity measurements. No signifi-
cant difference in the ability of tumor cells to adhere to the
endothelium was observed between HBL100 breast tumor
cells expressing Cx43 and tumor cells lacking Cx43 expres-
sion (Fig. 5), suggesting that the increased efficiency of dia-
pedesis was not due to increased cellular adhesion.
To determine whether GJIC was required to increase HBL100
tumor cell diapedesis, we chemically blocked gap junctional
coupling using CBX. HMVEC monolayers were preloaded
with calcein dye and fluorescence recovery after photobleach-
ing (FRAP) analysis was first used to determine whether CBX
effectively blocked gap junctions in endothelial cells. Individual
cells within the calcein-AM loaded monolayer were bleached
and recovery of fluorescence was quantified. Our results dem-
onstrated that, in the presence of 150 µM CBX, fluorescence
recovery in the bleached cell was prevented (Fig. 6a, trian-
gles), indicating lack of homocellular gap junctional coupling.
In GZA treated monolayers (negative control), however, recov-
ery of fluorescence occurred at levels similar to those in
untreated cells (Fig. 6a, rectangles and circles, respectively),
indicating functional homocellular gap junctional coupling
between adjacent endothelial cells.
To determine whether CBX would impair the Cx43-induced
increase in diapedesis of HBL100Cx43 cells, HMVEC monol-
ayers were pretreated with 150 µM CBX, or 150 µM GZA
prior to adding tumor cells (Fig. 6b). In the presence of GZA
HBL100Cx43 cells were more efficient at diapedesis com-
pared to HBL100v control cells. A significant decrease in dia-
pedesis efficiency in the presence of the gap junctional
blocker CBX, however, was observed for both HBL100v and
HBL100Cx43 cells. This finding suggests that gap junctional
coupling between endothelial cells partially regulates diaped-
esis efficiency of tumor cells regardless of their Cx43
expression.
To determine if GJIC was necessary for Cx43-linked increase
in diapedesis and, more specifically, if heterocellular GJIC was
necessary between tumor and endothelial cells, we compared
diapedesis of HBL100 cells that expressed either the func-
tional or non-functional Cx43 (GFP-Cx43). Previous studies
showed that GFP fused to the amino terminus of Cx43 (GFP-
Cx43) results in a chimeric connexin that can traffic and form
gap junction-like structures at cell-cell contacts, but these
structures are not functional [33] and also functional
Figure 4
Connexin43 (Cx43) enhances tumor cell diapedesis Connexin43 (Cx43) enhances tumor cell diapedesis. HBL100 and 
HBL100v cells or cells expressing functional Cx43 (HBL100Cx43) 
were co-cultured with HMVEC monolayers for 1, 5 and 7 h. (a) Adher-
ent cells in the process of diapedesis and cells that had completed 
transmigration were scored together as migrating. Compared to 
HBL100v or HBL100 wild-type cells a two-fold increase in diapedesis 
of HBL100Cx43 cells was seen at 1, 5 and 7 h. (b) At 7 h the relative 
proportion of cells at different stages of migration was evaluated. Com-
pared to control cells, the observed two-fold increase in the number of 
transmigrating HBL100Cx43 cells correlated with a two-fold decrease 
in the number of HBL100Cx43 cells located on top of the monolayer. 
No significant difference in the proportion of cells underneath the 
endothelium was observed between the Cx43 expressing and non-
expressing HBL100 cells. Data are expressed as the mean percentage 
± SEM of three independent experiments performed in triplicate (*p < 
0.05).Available online http://breast-cancer-research.com/content/7/4/R522
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hemichannels do not form [43]. HBL100, HBL100v,
HBL100Cx43, or HBL100GFP-Cx43 cells were co-cultured
with HMVEC for 7 h and scored according to the described
criteria for stages of migration (Fig. 1). After 7 h of co-culture
the percentage of migrating HBL100GFP-Cx43 cells was
similar to that of migrating HBL100 and HBL100v cells,
whereas diapedesis efficiency of HBL100Cx43 cells was
more than 50% higher (Fig. 7). This result suggests that the
presence of Cx43 protein in the tumor cell alone is not respon-
sible for the observed increase in diapedesis, but that hetero-
cellular GJIC between tumor cells and endothelial cells is
required to augment the efficiency of diapedesis of HBL100
cells.
Discussion
Previous work by Kramer and Nicolson [44] evaluated
melanoma cell diapedesis through endothelial monolayers by
time-lapse, phase-contrast, scanning and transmission elec-
tron microscopy. In our study we used an in vitro cell culture
model to evaluate the role of Cx43 expression in diapedesis of
breast tumor cells through the endothelium by confocal micro-
scopy. Our in vitro cell culture model enables us to dissect var-
ious stages of diapedesis and to examine the molecules or
mechanisms involved in each of these stages [9,35,37,39-
41]. Detailed morphological analysis by confocal microscopy
Figure 5
Connexin43 (Cx43) expression does not affect tumor cell adhesion to  the endothelium Connexin43 (Cx43) expression does not affect tumor cell adhesion to 
the endothelium. HBL100, HBL100v and Cx43 expressing HBL100 
cells (HBL100Cx43) were labeled with dioctadecyl-3, 3,3', 3'-tetrame-
thylindocarbocyanine percholate (DiI), added for 1 h to endothelial 
monolayers and co-cultures were washed to remove non-adherent 
cells. Fluorescence intensity measurements revealed no significant dif-
ference in the number of tumor cells attached to the endothelium 
regardless of cell type. Data are expressed as mean percentage ± SEM 
of three independent experiments with eight replicates.
Figure 6
Carbenoxolone (CBX) blocks gap junctional intercellular communica- tion (GJIC) in human microvascular endothelial cell (HMVEC) monolay- ers and decreases tumor cell diapedesis Carbenoxolone (CBX) blocks gap junctional intercellular communica-
tion (GJIC) in human microvascular endothelial cell (HMVEC) monolay-
ers and decreases tumor cell diapedesis. (a) To determine the extent 
by which GJIC in HMVEC was blocked by CBX, monolayers were pre-
treated with 150 µM CBX or the inactive analog glycyrrhizic acid (GZA) 
and analyzed by fluorescence recovery after photo-bleaching (FRAP). 
FRAP analysis revealed that fluorescence recovery by homocellular gap 
junctional coupling was blocked by 150 µM CBX (triangles), while 
recovery of fluorescence was observed in untreated (circles) or GZA 
treated monolayers (rectangles). Data represent three independent 
experiments. (b) To determine the effect of blocking gap junctional cou-
pling on diapedesis, HMVEC monolayers were pre-treated with 150 
µM CBX, or the inactive analog GZA and HBL100v cells or cells 
expressing functional Cx43 (HBL100Cx43) were co-cultured for 7 h 
with HMVEC monolayers, fixed and labeled for F-actin. Tumor cells 
were scored according to the criteria specified in Fig 1. In comparison 
to the inactive analog (GZA), treatment with CBX resulted in a signifi-
cant decrease in the number of migrating HBL100v and HBL100Cx43 
cells. Data are expressed as the mean percentage of three independent 
experiments ± SEM performed in duplicate or triplicate. Identical letters 
over bars indicate no statistical significance while different letters sig-
nify statistical significance (p < 0.01).Breast Cancer Research    Vol 7 No 4    Pollmann et al.
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allowed us to classify HBL100 breast tumor cell diapedesis
into three stages (Fig. 1). First HBL100 breast cancer cells
adhered to the endothelium but maintained a round morphol-
ogy while often extending finger-like processes. This is similar
to the behavior of PC3 prostate tumor cells [11] but differs
from our previous findings with WM239 melanoma cells,
which tended to spread along the endothelial cell surface
before diapedesis and extended clusters of blebs at the heter-
otypic contact site between tumor cells and endothelial cells
[9]. It is, therefore, likely that the adhesive interactions
between tumor cells and the mechanisms of communication
between endothelial cells and tumor cells are cell type specific
and may regulate important aspects of diapedesis. During dia-
pedesis, HBL100 cells, like melanoma cells, sent out projec-
tions through the endothelium, resulting in a localized
retraction of the endothelial cells [9]. Compared to melanoma
cells, the width of the opening through which HBL100 cells
migrate appeared to be smaller and is lined by F-actin.
HBL100 cells that came into contact with the underlying base-
ment membrane spread and flattened out, forming stress fib-
ers on the extracellular matrix, while the endothelium reformed
cell-cell junctions over the top of the tumor cell. This stage of
diapedesis is very similar in WM239 melanoma cells and PC3
prostate tumor cells [9,11]. Exogenous expression of Cx43 in
HBL100 cells did not appear to have an effect on their adhe-
sive properties to endothelial surfaces nor their morphology at
any of the stages of diapedesis.
Interestingly, glioma cells engineered to express Cx43 formed
bigger homocellular aggregates compared to control cells
[45], suggesting that increased aggregation may be due to
increased adhesive properties of the cells as a result of Cx43
expression.
In our study we demonstrated that HBL100 breast cancer
cells engineered to express Cx43 were able to localize Cx43
protein to cell-cell contacts during diapedesis, forming
communication competent gap junctions with endothelial cells
(Fig. 3b,g–j). Previous studies by El-Sabban et al. [15] using
melanoma cells expressing Cx43 support these findings,
reporting that highly metastatic melanoma cells with higher
levels of Cx43 mRNA coupled more efficiently to endothelial
cells than low metastatic tumor cells with low amounts of
Cx43 mRNA [15]. Although these and other reports
demonstrated gap junctional coupling between tumor cells
and endothelial cells [15-17] it was unclear if GJIC was
required for increased tumor cell diapedesis. Whereas previ-
ous reports have shown Cx43 localized at contact sites
between tumor cells and endothelial cells [16], our study dem-
onstrated for the first time that Cx43 protein can be localized
at the cell-cell interface between endothelial cells and tumor
cells during the process of diapedesis. This localization of
Cx43 to tumor/endothelial cell boundaries and the establish-
ment of functional heterocellular coupling indicated that GJIC
facilitates diapedesis. This finding is surprising because
previous work has demonstrated a downregulation of con-
nexin expression and gap junctional communication in primary
tumor [29,46-49]. In addition, other studies have demon-
strated reintroduction of connexins in primary tumor cells acts
as a tumor suppressor in several cancers [34,50-52]. It is con-
ceivable that tumor cells with low levels of connexins may
encounter factors within the circulation such as growth factors
or cytokines that could restore connexin expression previously
lost in the primary tumor. For example it has been shown that
vascular endothelial growth factor (VEGF), IL-1β  and IL-6 are
upregulated in serum of cancer patients [53,54] and that
VEGF and IL-1β  can increase Cx43 expression [55,56].
Increasing connexin expression in poorly invasive tumor cells,
therefore, may increase their ability to migrate through the
endothelium, allowing them to invade other tissues where they
may develop into more aggressive tumors.
Our study shows that HBL100 breast tumor cells expressing
Cx43 migrated more efficiently through the endothelium than
their counterparts lacking Cx43 expression. This finding sug-
gests that gap junctions and/or Cx43 expression in these cells
may affect the motile behavior of cells by changing the kinetics
Figure 7
Non-functional Connexin43 (Cx43) does not enhance tumor cell  diapedesis Non-functional Connexin43 (Cx43) does not enhance tumor cell dia-
pedesis. HBL100 cells were transfected with Cx43 to which green flu-
orescent protein (GFP) was fused at the amino terminus (GFP-Cx43) to 
make it non-functional. Diapedesis of HBL100v cells and cells express-
ing functional (HBL100Cx43) or non-functional (HBL100GFP-Cx43) 
Cx43 was scored following co-culture with human microvascular 
endothelial cell (HMVEC) monolayers for 7 h. Analysis revealed that 
HBL100 cells transfected with GFP-Cx43 had an efficiency of diapede-
sis similar to HBL100v control cells in contrast to HBL100Cx43 cells, 
which showed significantly greater numbers of migrating cells. Data are 
expressed as the mean percentage ± SEM of five independent experi-
ments in duplicate or triplicate (* p < 0.05).Available online http://breast-cancer-research.com/content/7/4/R522
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of diapedesis of individual cells. The fact that Cx43 expression
can influence the motile behavior of cells has been previously
demonstrated [57]. For example, HeLa cells transfected with
Cx43 formed functional gap junctions with embryonic chicken
heart cells, and were more invasive into the ventricle of the
heart compared to their wild-type counterparts, supporting the
hypothesis that Cx43 expressing cells can be more invasive
[57]. In addition, Cx26 expressing BL6 mouse melanoma cells
had increased metastatic properties in vivo [17].
Cellular motility may also be affected by changes in cadherin
expression. Down regulation of E-cadherin expression or func-
tion correlates with tumor development and malignancy
[58,59], while N-cadherin expression appears to enhance cell
motility [60,61]. Interestingly, both Cx43 and N-cadherin
appear to regulate mouse neural crest cell motility, perhaps by
engaging p120ctn signaling [62]. At present, a functional rela-
tionship between cadherin expression and Cx43 expression in
breast tumor cell motility is largely unknown and the role of
ZO-1 or p120ctn, which interact with both cadherins and con-
nexins, in this process needs to be examined.
It was important to distinguish whether the observed increase
in diapedesis efficiency was due to enhanced expression of
Cx43 in the tumor cell or due to the exchange of signals
between tumor and endothelial cells via functional gap junc-
tions. Two approaches were used to examine this issue. First,
we blocked homocellular and heterocellular GJIC. In the
presence of the gap junctional blocker, diapedesis efficiencies
were significantly reduced in both the control HBL100v cells
and the Cx43 expressing HBL100 cells (HBL100Cx43) (Fig.
6b), suggesting gap junctional coupling between the adjacent
endothelial cells is important in regulating tumor cell
diapedesis efficiency regardless of their connexin content.
Disruption of homocellular endothelial GJIC may compromise
the normal function of the endothelium required for blood
borne cells to cross this barrier. Our findings therefore support
the hypothesis that the endothelium plays an active role in the
process of diapedesis in line with previous work demonstrat-
ing that during diapedesis endothelial cells require N-cadherin
to reform the junctions above melanoma cells [9]. In the sec-
ond approach, heterocellular coupling between tumor cells
and endothelial cells was specifically disrupted in HBL100
breast tumor cells by expressing a non-functional Cx43 in
which GFP was tagged to the amino terminus of the Cx43
polypeptide. This chimeric connexin is capable of forming gap
junction-like structures at the cell surface but incapable of
forming functional gap junction channels or functional
hemichannels as revealed by dye [33] and electrical [43] cou-
pling assays. Our findings reveal that the diapedesis efficiency
of tumor cells expressing the non-functional Cx43 was similar
to that of wild-type and empty vector control cells (Fig. 7), sug-
gesting that heterocellular GJIC between tumor and endothe-
lial cells is necessary to enhance diapedesis. It is possible that
fusing GFP to the amino terminus of Cx43 may be blocking
Cx43 binding proteins that could be required for efficient
tumor cell diapedesis, although, to date, no amino-terminal
Cx43 binding proteins have been identified. Together with our
finding that CBX decreases the efficiency of tumor cell dia-
pedesis, our results support the hypothesis that GJIC facili-
tates tumor cell diapedesis.
Several possible scenarios could explain how GJIC might
modulate tumor cell diapedesis. Tumor cells might send sig-
nals to the endothelium, resulting in the release of endothelial
proteolytic enzymes, facilitating endothelial cell retraction. A
recent study by Bazarbachi et al. [63] demonstrated that neo-
plastic lymphocytes triggered increased matrix metalloprotein-
ase activity in endothelial cells. This activity was reduced in the
presence of the gap junctional blocker 18α  glycyrrhetinic acid
[63]. Tumor cells may also send signals, such as inositol tri-
phosphate (IP3), through gap junctions that directly trigger the
weakening of inter-endothelial junctions. IP3 can pass between
adjacent cells through gap junctions [64] and regulate
intracellular calcium levels [65]. Interestingly, the depletion of
calcium stores in the endothelium inhibited extravasation of
MCF-7 tumor cells [66] and elevated levels of intracellular
calcium resulted in the transient phosphorylation of myosin
light chain [67,68], which is known to increase endothelial per-
meability [69]. Endothelial cells may also send signals through
gap junctions to tumor cells, resulting in the upregulation of
proteins involved in cellular motility (such as Rho GTPases,
protein kinase C, and phosphoinositide 3 kinase).
Although it has been suggested that extravasation may not be
a limiting factor for metastasis [70-72], metastatic ability
appears to be correlated with the capability of tumor cells to
communicate with endothelial cells as previously demon-
strated in metastatic B16-F10 melanoma cells [15-17].
Transient re-expression of connexins in tumor cells, and the
exchange of molecules between tumor cells and endothelial
cells through gap junctions, might also affect tumor cells in
their behavior following extravasation when these cells interact
with the extracellular matrix and form secondary tumors. For
example, melanoma cells invading into the dermis (i.e. towards
the endothelium) have an increase in Cx26 expression com-
pared to those located in the basal layer of the epidermis [17].
These invading melanoma cells showed stronger heterocellu-
lar coupling to the endothelium than homocellular coupling
with each other (in vitro). Furthermore, squamous cell carcino-
mas exhibited reduced levels of Cx26 and Cx43 expression at
early stages of mouse skin carcinogenesis and sites of inva-
sion, although Cx26 expression was partially restored in these
cells at metastatic sites within the lymph nodes [73].
Conclusion
Our work supports the hypothesis that heterocellular gap junc-
tional coupling between tumor cells and endothelium may reg-
ulate the extravasation of at least some poorly invasive tumor
cells such as HBL100 breast tumor cells, and that homocellu-Breast Cancer Research    Vol 7 No 4    Pollmann et al.
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lar GJIC amongst endothelial cells may play an active role in
this process. These studies would suggest that even though
extravasation may not necessarily be a rate limiting step in
metastasis, there might be therapeutic advantages to design-
ing drugs or reagents that inhibit vascular homocellular and
heterocellular GJIC as a means of reducing metastatic spread
of tumor cells.
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